ARTIFICIAL INTELLIGENCE (AI) IN BIOTECHNOLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Artificial Intelligence (AI) in Biotechnology Market, By Component (Software, Hardware, Services), By Application (Drug Discovery & Development, Clinical Trials & Optimization, Medical Imaging, Diagnostics, Others), By End User (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Healthcare Providers, CRO & CDMO, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In: 25 Feb, 2025
Code: CMI7132
Pages: 171
Formats: Excel and PDF
Industry: Healthcare IT
- Historical Range: 2020 - 2024
- Forecast Period: 2025 - 2032

The field of biotechnology has witnessed rapid advancements due to technological developments in various domains including artificial intelligence and machine learning. AI is being increasingly used in biotechnology for applications ranging from drug discovery and genome analysis to clinical trial monitoring and precision medicine. AI tools help researchers to process huge volumes of genomic and proteomic data and gain novel insights into disease mechanisms. Several AI-powered techniques like deep learning, neural networks, natural language processing, and others assist in critical functions like target identification, lead optimization, toxicity prediction and biomarker discovery, thus, significantly accelerating the drug development process. AI help biotech companies in monitoring and managing clinical trials more efficiently. It also has promising applications in personalized medicine by supporting treatment recommendations tailored to individual patients' genetic profile and medical history. Global AI in biotechnology market growth is driven by rising adoption of these technologies in pharma/biotech industry and healthcare.

Market Dynamic:

Global AI in biotechnology market growth is driven by factors like increasing funding for AI startups developing solutions for healthcare and life sciences, growing volumes of complex biological and patient-generated healthcare data requiring sophisticated analysis, and rising need to enhance R&D productivity and reduce costs in drug discovery. However, factors like lack of skilled workforce, data quality issues, security and regulatory concerns related to AI and big data can hamper its adoption. Expanding applications of predictive analytics, machine learning and artificial intelligence in precision medicine, personalized therapeutics, gene therapies and diagnostics can offer market growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global AI in biotechnology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global AI in biotechnology market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Intel Corporation, NVIDIA Corporation, IBM Corporation, Microsoft Corporation, Amazon Web Services, Anthropic, Berg Health, Deep Genomics, Enlitic, twoXAR, and Insilico Medicine
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global AI in biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation-

By Component
- Software
- Hardware
- Services
By Application
- Drug Discovery & Development
- Clinical Trials & Optimization
- Medical Imaging
- Diagnostics
- Others
By End User
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Institutes
- Healthcare Providers
- CRO & CDMO
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AstraZeneca
- Bristol-Myers Squibb
- Gilead Sciences, Inc.
- Sanofi
- Abbott Laboratories
- Biogen
- Pfizer, Inc.
- Novo Nordisk A/S
- Amgen, Inc.
- Merck KGaA
- Johnson & Johnson Services, Inc.
- Hoffmann-La Roche Ltd.
- Novartis AG
- Deep Genomics
- NVIDIA Corporation
- Verge Genomics
- Recursion Pharmaceuticals

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Component
  - Market Snapshot, By Application
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
Global AI in Biotechnology Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
Global AI in Biotechnology Market, By Component, 2020 – 2032, (USD Bn)
- Overview
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- Software
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Hardware
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Services
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Global AI in Biotechnology Market, By Application, 2020 – 2032, (USD Bn)
- Overview
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- Drug Discovery & Development
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Clinical Trials & Optimization
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Medical Imaging
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Diagnostics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Global AI in Biotechnology Market, By End User, 2020 – 2032, (USD Bn)
- Overview
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- Pharmaceutical Companies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Biotechnology Companies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Academic & Research Institutes
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Healthcare Providers
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- CRO & CDMO
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
Global AI in Biotechnology Market, By Region, 2020 – 2032, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, For Region, 2021–2032
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Component, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Component, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Component, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Component, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Component, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Component, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 – 2032, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - AstraZeneca
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Bristol-Myers Squibb
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Gilead Sciences, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sanofi
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Abbott Laboratories
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Biogen
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Pfizer, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Novo Nordisk A/S
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Amgen, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Merck KGaA
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Johnson & Johnson Services, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - F. Hoffmann-La Roche Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Novartis AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Deep Genomics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - NVIDIA Corporation
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Verge Genomics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Recursion Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 32 market data tables and 28 figures on "AI in Biotechnology Market” - Global forecast to 2032

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now